^
    over1year
    CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection (clinicaltrials.gov)
    P1, N=30, Recruiting, CARsgen Therapeutics Co., Ltd.
    New P1 trial • CAR T-Cell Therapy
    |
    CT011